FDA Inspection 759369 — Aesica Pharmaceutical GmbH

Aesica Pharmaceutical GmbH — FEI 3002943189

The FDA completed an inspection of Aesica Pharmaceutical GmbH on November 11, 2011 in Monheim am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 11, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monheim am Rhein (Germany)

Citations

IDCFRDescription
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action